AEHR Aehr Test Systems, Inc. - Fundamental Analysis
BEARISH
Sign in to save
Save this symbol to a watchlist or track a position.
AEHR Stock | Fundamental Analysis & Investment Insights
NASDAQ
Technology
Semiconductor Equipment & Materials
Current Price
Live
$33.6
Analyst Target
$24.67
-26.6%
Downside
52W High
$37.49
52W Low
$6.27
At a glance
Key valuation, profitability, growth, and risk metrics.
Updated Feb 21, 2026
Market cap
$1.03B
P/E
N/A
ROE
-7.0%
Profit margin
-16.6%
Debt/Equity
0.08
Dividend yield
N/A
AI Analysis
Powered by advanced machine learning algorithms
Confidence Score
85%
Analysis Accuracy
AEHR's Piotroski F-Score of 6/9 indicates a stable but not strong financial foundation, with no Altman Z-Score available to assess bankruptcy risk. The company exhibits severe profitability issues, including a negative profit margin of -16.63% and operating margin of -49.18%, alongside a 26.5% year-over-year revenue decline. Despite a strong cash position (current ratio of 10.62 and debt/equity of 0.08), the lack of earnings consistency and recent insider selling raise red flags. The stock trades at an extremely high forward P/E of 448.00, suggesting extreme growth expectations that are not currently supported by fundamentals.
Key Strengths
Strong liquidity with a current ratio of 10.62 and quick ratio of 5.18
Low debt/equity ratio of 0.08, indicating minimal financial leverage
Historical ability to beat earnings estimates in prior quarters (e.g., +700% surprise in Q2 2024)
Significant 5-year stock appreciation (+987.4%), indicating strong market momentum
Recent insider activity includes multiple sales, but no buys, suggesting cautious sentiment
Key Risks
Negative profit margin (-16.63%) and operating margin (-49.18%) indicate fundamental profitability challenges
26.5% year-over-year revenue decline signals deteriorating business momentum
Forward P/E of 448.00 is unsustainable without significant earnings recovery
Insider selling of $1.02M in the last 6 months, with no buy activity, signals potential lack of confidence
No Graham Number or intrinsic value estimate available, making valuation difficult to anchor
Performance Snowflake
Multi-dimensional analysis across 5 key categories
Overall
34
Weak
20
35
65
50
0
AI Verdict
Weak
Key drivers: Negative profitability and declining revenue, Extremely high valuation multiples, Lack of earnings consistency, Bearish insider activity, No Altman Z-Score to confirm financial safety
Confidence
85%
Value
20/100
Ref P/E, PEG, Graham Number
Positives
- Low debt/equity ratio (0.08) and high current ratio (10.62) suggest strong balance sheet strength
Watchpoints
- Forward P/E of 448.00 is extremely high and not justified by current earnings
- No Graham Number or intrinsic value estimate available
- Price/Sales of 19.33 is exceptionally high for a loss-making company
Future
35/100
Ref Growth rates
Positives
- Historical earnings surprises (e.g., +700% in Q2 2024) suggest potential for upside if turnaround occurs
- 5-year stock return of +987.4% indicates strong market belief in future growth
Watchpoints
- Revenue growth is down 26.5% YoY, indicating ongoing business contraction
- Earnings growth is negative (-300% YoY), with no sustainable path to recovery evident
- No forward guidance or clear catalysts for improvement
Past
65/100
Ref Historical trends
Positives
- Consistent history of beating earnings estimates in prior quarters (e.g., 7 out of 10 in 2023)
- Strong EPS growth in 2022–2023 (e.g., +400% surprise in Q4 2022)
- Positive Q/Q EPS growth in 2024 (e.g., +366.7% in Q3 2024)
Watchpoints
- Recent earnings performance has deteriorated sharply (e.g., -500% Q/Q EPS growth)
- Negative EPS in multiple recent quarters (e.g., -$0.07 in Q1 2026)
- Declining trend in earnings surprise magnitude over time
Health
50/100
Ref Altman Z-Score, Piotroski F-Score
Positives
- Piotroski F-Score of 6/9 indicates stable financial health
- Low debt/equity (0.08) and high liquidity (current ratio 10.62) reduce immediate solvency risk
Watchpoints
- No Altman Z-Score available, making distress risk assessment impossible
- Negative ROE (-6.97%) and ROA (-5.01%) indicate poor capital efficiency
- Operating margin of -49.18% reflects deep operational inefficiency
Dividend
0/100
Ref Yield, Payout
Positives
No standout positives identified.
Watchpoints
- No dividend yield or payout ratio available
- Dividend strength is 0/100, indicating no dividend policy
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Current Price
$33.6
Analyst Target
$24.67
Upside/Downside
-26.6%
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for AEHR and closest competitors.
Updated 2026-02-20
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
AEHR
Aehr Test Systems, Inc.
Primary
|
+987.4% | +3.0% | +177.7% | +85.6% | +15.1% | +16.5% |
|
AMPL
Amplitude, Inc.
Peer
|
-86.8% | -53.4% | -41.6% | -37.3% | -37.9% | -21.2% |
|
ALNT
Allient Inc.
Peer
|
+103.4% | +60.1% | +167.5% | +56.7% | +15.3% | +7.8% |
|
AXTI
AXT, Inc.
Peer
|
+47.3% | +211.3% | +656.5% | +640.4% | +15.9% | -21.2% |
|
ALIT
Alight, Inc.
Peer
|
-87.9% | -83.0% | -77.8% | -73.4% | -24.4% | -5.1% |
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Historical data shows last 12 quarters (3 years)
Valuation Metrics
Key valuation ratios and pricing indicators
P/E Ratio
N/A
Forward P/E
448.0
PEG Ratio
N/A
P/B Ratio
7.87
P/S Ratio
19.33
EV/Revenue
17.02
EV/EBITDA
-102.13
Market Cap
$1.03B
Profitability
Profit margins and return metrics
Profit Margin
-16.63%
Operating Margin
-49.18%
Gross Margin
33.28%
ROE
-6.97%
ROA
-5.01%
Growth
Revenue and earnings growth rates
Revenue Growth
-26.5%
Earnings Growth
N/A
Q/Q Revenue Growth
N/A
Q/Q Earnings Growth
N/A
Financial Health
Balance sheet strength and liquidity metrics
Debt/Equity
0.08
Low debt
Current Ratio
10.62
Strong
Quick Ratio
5.18
Excellent
Cash/Share
$1.01
Quarterly Earnings History
EPS performance vs analyst estimates
2026-04-07
$N/A
2026-01-08
$-0.04
-9.1% surprise
2025-10-06
$0.01
2025-07-08
$-0.01
+33.3% surprise
Technology Sector Comparison
Comparing AEHR against 149 companies in the Technology sector
(11 bullish, 67 neutral, 71 bearish)
Return on Equity (ROE)
-6.97%
This Stock
vs
-6.46%
Sector Avg
+7.9%
(Above Avg)
Profit Margin
-16.63%
This Stock
vs
-9.26%
Sector Avg
+79.6%
(Superior)
Debt to Equity
0.08
This Stock
vs
0.7
Sector Avg
-88.9%
(Less Debt)
Revenue Growth
-26.5%
This Stock
vs
61.74%
Sector Avg
-142.9%
(Slower)
Current Ratio
10.62
This Stock
vs
3.39
Sector Avg
+213.2%
(Stronger)
Similar Companies
Peer comparison within the same industry
| Company | AI Rating | Market Cap | P/E | ROE | Profit Margin | Price | |
|---|---|---|---|---|---|---|---|
|
AEHR
Aehr Test Systems, Inc.
|
BEARISH | $1.03B | - | -7.0% | -16.6% | $33.6 | |
|
AMPL
Amplitude, Inc.
|
BEARISH | $966.55M | - | -37.5% | -31.4% | $7.23 | |
|
ALNT
Allient Inc.
|
BEARISH | $1.11B | 55.71 | 6.6% | 3.5% | $65.74 | |
|
AXTI
AXT, Inc.
|
NEUTRAL | $943.24M | - | -9.9% | -25.2% | $17.4 | |
|
ALIT
Alight, Inc.
|
BEARISH | $818.74M | - | -66.9% | -94.2% | $1.49 |
Recent Insider Trading
Insider buy and sell transactions from the last 6 months
| Date | Insider | Position | Transaction | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-13 | POSEDEL RHEA J | Director | Sale | 13,998 | $420,151 |
| 2026-02-09 | SPORCK ALISTAIR N | Officer | Sale | 3,000 | $82,716 |
| 2026-02-04 | SLAYEN HOWARD T | Director | Gift | 15,000 | - |
| 2026-01-22 | OLIPHANT LAURA | Director | Sale | 4,546 | $142,750 |
| 2025-11-05 | SLAYEN HOWARD T | Director | Sale | 6,000 | $154,357 |
| 2025-10-22 | ROGERS VERNON | Officer | Option Exercise | 110,468 | $224,250 |
| 2025-10-09 | DANESH FARIBA | Director | Sale | 9,000 | $223,101 |
| 2025-09-24 | SLAYEN HOWARD T | Director | Gift | 5,000 | - |
| 2025-09-02 | SLAYEN HOWARD T | Director | Gift | 639 | - |
Insider transactions can signal confidence or concerns about company prospects
Wall Street Analysts
Professional analyst ratings and price targets
Consensus
BUY
3 analysts
Craig-Hallum
2026-01-09
Hold
Hold
Lake Street
2025-12-17
Buy
Past News Coverage
Recent headlines mentioning AEHR from our newsroom.
Newest → oldest
No matching news yet.